Apogee Therapeutics, Inc. · NASDAQ:APGE

T. Rowe Price Investment Management, Inc. reported a 16.80% stake in Apogee Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed Apr 8, 2026

T. Rowe Price Investment Management, Inc. reported a 16.80% stake in Apogee Therapeutics, Inc., 10,291,220 shares, as a passive investor on Mar 31, 2026. Filed Apr 8, 2026 (Schedule 13G/A).

Stake
16.80%
Shares
10,291,220
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.16.80%10,291,220

Source

View original at SEC

Related